Literature DB >> 30836073

Mathematical modeling of tumor-immune cell interactions.

Grace E Mahlbacher1, Kara C Reihmer1, Hermann B Frieboes2.   

Abstract

The anti-tumor activity of the immune system is increasingly recognized as critical for the mounting of a prolonged and effective response to cancer growth and invasion, and for preventing recurrence following resection or treatment. As the knowledge of tumor-immune cell interactions has advanced, experimental investigation has been complemented by mathematical modeling with the goal to quantify and predict these interactions. This succinct review offers an overview of recent tumor-immune continuum modeling approaches, highlighting spatial models. The focus is on work published in the past decade, incorporating one or more immune cell types and evaluating immune cell effects on tumor progression. Due to their relevance to cancer, the following immune cells and their combinations are described: macrophages, Cytotoxic T Lymphocytes, Natural Killer cells, dendritic cells, T regulatory cells, and CD4+ T helper cells. Although important insight has been gained from a mathematical modeling perspective, the development of models incorporating patient-specific data remains an important goal yet to be realized for potential clinical benefit.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Cancer immunology; Cancer immunotherapy; Computational simulation; Immune system; Mathematical modeling; Onco-immunotherapy; Tumor growth

Mesh:

Year:  2019        PMID: 30836073      PMCID: PMC6579737          DOI: 10.1016/j.jtbi.2019.03.002

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  99 in total

1.  Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies.

Authors:  Steven R McDougall; Alexander R A Anderson; Mark A J Chaplain
Journal:  J Theor Biol       Date:  2006-02-17       Impact factor: 2.691

2.  A validated mathematical model of cell-mediated immune response to tumor growth.

Authors:  Lisette G de Pillis; Ami E Radunskaya; Charles L Wiseman
Journal:  Cancer Res       Date:  2005-09-01       Impact factor: 12.701

3.  Larger numbers of immature dendritic cells augment an anti-tumor effect against established murine melanoma cells.

Authors:  Tae-Hyung Lee; Young-Hun Cho; Min-Geol Lee
Journal:  Biotechnol Lett       Date:  2006-12-19       Impact factor: 2.461

4.  Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model.

Authors:  Antonio Cappuccio; Moran Elishmereni; Zvia Agur
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

5.  Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour.

Authors:  Anastasios Matzavinos; Mark A J Chaplain; Vladimir A Kuznetsov
Journal:  Math Med Biol       Date:  2004-03       Impact factor: 1.854

6.  Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction.

Authors:  Burkhard Ludewig; Philippe Krebs; Tobias Junt; Helen Metters; Neville J Ford; Roy M Anderson; Gennady Bocharov
Journal:  Eur J Immunol       Date:  2004-09       Impact factor: 5.532

Review 7.  The immunobiology of cancer immunosurveillance and immunoediting.

Authors:  Gavin P Dunn; Lloyd J Old; Robert D Schreiber
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

8.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

Authors:  Michele De Palma; Mary Anna Venneri; Rossella Galli; Lucia Sergi Sergi; Letterio S Politi; Maurilio Sampaolesi; Luigi Naldini
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

9.  Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites.

Authors:  Markus R Owen; Helen M Byrne; Claire E Lewis
Journal:  J Theor Biol       Date:  2004-02-21       Impact factor: 2.691

Review 10.  Targeting cytotoxic T lymphocytes for cancer immunotherapy.

Authors:  J Maher; E T Davies
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

View more
  20 in total

1.  Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization.

Authors:  Fransisca Leonard; Louis T Curtis; Ahmed R Hamed; Carolyn Zhang; Eric Chau; Devon Sieving; Biana Godin; Hermann B Frieboes
Journal:  Cancer Immunol Immunother       Date:  2020-02-08       Impact factor: 6.968

2.  Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.

Authors:  Louis T Curtis; Susanne Sebens; Hermann B Frieboes
Journal:  Cancer Immunol Immunother       Date:  2020-11-12       Impact factor: 6.968

3.  Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy.

Authors:  Jason I Griffiths; Pierre Wallet; Lance T Pflieger; David Stenehjem; Xuan Liu; Patrick A Cosgrove; Neena A Leggett; Jasmine A McQuerry; Gajendra Shrestha; Maura Rossetti; Gemalene Sunga; Philip J Moos; Frederick R Adler; Jeffrey T Chang; Sunil Sharma; Andrea H Bild
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-22       Impact factor: 11.205

Review 4.  Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology.

Authors:  Chengyue Wu; Guillermo Lorenzo; David A Hormuth; Ernesto A B F Lima; Kalina P Slavkova; Julie C DiCarlo; John Virostko; Caleb M Phillips; Debra Patt; Caroline Chung; Thomas E Yankeelov
Journal:  Biophys Rev (Melville)       Date:  2022-05-17

5.  Analysis of the Equilibrium Phase in Immune-Controlled Tumors Provides Hints for Designing Better Strategies for Cancer Treatment.

Authors:  Kevin Atsou; Sokchea Khou; Fabienne Anjuère; Véronique M Braud; Thierry Goudon
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

6.  Modeling cancer immunoediting in tumor microenvironment with system characterization through the ising-model Hamiltonian.

Authors:  Alfonso Rojas-Domínguez; Renato Arroyo-Duarte; Fernando Rincón-Vieyra; Matías Alvarado-Mentado
Journal:  BMC Bioinformatics       Date:  2022-05-30       Impact factor: 3.307

7.  Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors.

Authors:  Benjamin M Ellingson; Elizabeth R Gerstner; Andrew B Lassman; Caroline Chung; Howard Colman; Patricia E Cole; David Leung; Joshua E Allen; Manmeet S Ahluwalia; Jerrold Boxerman; Matthew Brown; Jonathan Goldin; Edjah Nduom; Islam Hassan; Mark R Gilbert; Ingo K Mellinghoff; Michael Weller; Susan Chang; David Arons; Clair Meehan; Wendy Selig; Kirk Tanner; W K Alfred Yung; Martin van den Bent; Patrick Y Wen; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2022-08-01       Impact factor: 13.029

Review 8.  Engineered in vitro tumor models for cell-based immunotherapy.

Authors:  Yuta Ando; Chelsea Mariano; Keyue Shen
Journal:  Acta Biomater       Date:  2021-04-20       Impact factor: 10.633

9.  Multi-objective optimization of tumor response to drug release from vasculature-bound nanoparticles.

Authors:  Ibrahim M Chamseddine; Hermann B Frieboes; Michael Kokkolaras
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

Review 10.  Modeling immune cell behavior across scales in cancer.

Authors:  Sahak Z Makaryan; Colin G Cess; Stacey D Finley
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.